Our department recently demonstrated that Pyrazinib, a small molecule drug, inhibits oxidative phosphorylation in both in vitro and ex vivo models of oesophageal adenocarcinoma (21, 58)
Ingredients: Low molecular weight fish collagen, anhydrous crystalline glucose, dried yeast (containing glutathione), concentrated orange powder (dextrin, gum arabic), natural orange flavor powder (natural flavor), vitamin C, citric acid anhydride, enzyme-treated stevia, vitamin E blend (DL--tocopheryl acetate, glucose syrup powder, modified starch, silicon dioxide), DL-malic acid, elastin hydrolysate (USA), hyaluronic acid blend (dextrin, hyaluronic acid, ronic acid, milk protein concentrate), vitamin A blend (glucose syrup powder, corn starch, vitamin A acetate, vitamin E), glycine, L-proline, L-cystine, concentrated white tomato extract powder, sucralose (sweetener), 17 types of mixed lactic acid bacteria
BMC Res Notes 2014: 7: 256
is a cofounder and shareholder of Casma Therapeutics and an advisory board member of Avilar Therapeutics and Amplify Therapeutics
